IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients

IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients

(1) <b>Background:</b> The high-grade neuroepithelial tumor of the central nervous system with BCOR alteration (HGNET-BCOR) is a highly malignant tumor. Preclinical models and molecular targets are urgently required for this cancer. Previous data suggest a potential role of insulin-like...

Full description

Bibliographic Details
Main Authors: Nadine Vewinger, Sabrina Huprich, Larissa Seidmann, Alexandra Russo, Francesca Alt, Hannah Bender, Clemens Sommer, David Samuel, Nadine Lehmann, Nora Backes, Lea Roth, Patrick N. Harter, Katharina Filipski, Jörg Faber, Claudia Paret
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:International Journal of Molecular Sciences
Subjects:
HGNET-BCOR
IGF1R
IGF2
ceritinib
vinblastine
Online Access:https://www.mdpi.com/1422-0067/20/12/3027

Internet

https://www.mdpi.com/1422-0067/20/12/3027

Similar Items